Back to search

Article

Probiotic Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation

2022-11-29

Abstract excerpt

Lactobacillus rhamnosus (LBS) is well documented probiotic strain in oncology and has a pivotal role in clinical applications. Here we investigated the Intervention effect of Lactobacillus rhamnosus on intestinal mucositis induced by cisplatin (CP). BALB/c mice were pre-treated with or without LBS via oral gavage, followed by induction of mucositis with cisplatin. Our results revealed that LBS-treated groups signi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
91199937-97d3-5980-a431-5b791ec11159
DOI
10.21203/rs.3.rs-2310317/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Probiotic Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal InflammationDOI 10.21203/rs.3.rs-2310317/v1
Select a neighboring publication to make it the new centre.